Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
71°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Moderna Inc
(NQ:
MRNA
)
71.99
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
20,397
Open
71.99
Bid (Size)
72.28 (3)
Ask (Size)
72.50 (1)
Prev. Close
71.99
Today's Range
71.99 - 71.99
52wk Range
62.55 - 170.47
Shares Outstanding
384,000,000
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse
Today 8:06 EDT
Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity Residential. Moderna has been disappointing, but Cramer likes Vertiv and...
Via
Benzinga
Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030
Today 5:49 EDT
These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.
Via
The Motley Fool
Performance
YTD
-36.01%
-36.01%
1 Month
-19.98%
-19.98%
3 Month
-45.98%
-45.98%
6 Month
-31.51%
-31.51%
1 Year
-30.87%
-30.87%
More News
Read More
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
September 17, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
16 Analysts Have This To Say About Moderna
September 13, 2024
Via
Benzinga
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years
September 13, 2024
Via
Benzinga
Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day
September 13, 2024
Via
Benzinga
S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers
September 17, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Momentum Investing Gives You An Edge, Until It Doesn’t
September 17, 2024
Via
Talk Markets
Small Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday?
September 17, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
What's Going On With Moderna Shares Tuesday?
September 17, 2024
Via
Benzinga
Exposures
COVID-19
Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older
September 17, 2024
Via
ACCESSWIRE
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline
September 16, 2024
From
Bernstein Liebhard LLP
Via
GlobeNewswire
DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
September 16, 2024
Via
Benzinga
Exposures
COVID-19
Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity
September 16, 2024
Via
MarketBeat
Exposures
COVID-19
Product Safety
Moderna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio?
September 15, 2024
Via
Benzinga
Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path?
September 15, 2024
Via
The Motley Fool
Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 14
September 14, 2024
Via
Talk Markets
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
September 14, 2024
Via
The Motley Fool
After Moderna's Shocking News, Is the Stock a Buy or a Sell?
September 14, 2024
Via
The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm
September 13, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target
September 13, 2024
Via
Benzinga
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
September 13, 2024
Via
Benzinga
Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day
September 13, 2024
Via
Investor's Business Daily
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
Via
The Motley Fool
A Bull Market Is Here: 2 High-Potential Stocks Down More Than 50% to Buy Right Now
September 13, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
